These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 17194724)

  • 21. Effects of stress-related peptides on chloride secretion in the mouse proximal colon.
    Liu S; Karo A; Agterberg S; Hua H; Bhargava A
    Neurogastroenterol Motil; 2021 Apr; 33(4):e14021. PubMed ID: 33118282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of corticotropin-releasing factor receptor-2 in stress-induced suppression of pulsatile luteinizing hormone secretion in the rat.
    Li XF; Bowe JE; Lightman SL; O'Byrne KT
    Endocrinology; 2005 Jan; 146(1):318-22. PubMed ID: 15388651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrathecal urocortin I in the spinal cord as a murine model of stress hormone-induced musculoskeletal and tactile hyperalgesia.
    Larson AA; Nunez MG; Kissel CL; Kovács KJ
    Eur J Neurosci; 2015 Nov; 42(10):2772-82. PubMed ID: 26332847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors.
    Perrin MH; Sutton SW; Cervini LA; Rivier JE; Vale WW
    J Pharmacol Exp Ther; 1999 Feb; 288(2):729-34. PubMed ID: 9918582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Corticotropin-releasing factor type 1 receptors mediate the visceral hyperalgesia induced by repeated psychological stress in rats.
    Larauche M; Bradesi S; Million M; McLean P; Taché Y; Mayer EA; McRoberts JA
    Am J Physiol Gastrointest Liver Physiol; 2008 Apr; 294(4):G1033-40. PubMed ID: 18308857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of urocortin, corticotropin-releasing factor (CRF) receptor agonist, and astressin, CRF receptor antagonist, on the sleep-wake pattern: analysis by radiotelemetry in conscious rats.
    Uchida M; Suzuki M; Shimizu K
    Biol Pharm Bull; 2007 Oct; 30(10):1895-7. PubMed ID: 17917258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urocortin prevents indomethacin-induced small intestinal lesions in rats through activation of CRF2 receptors.
    Kubo Y; Kumano A; Kamei K; Amagase K; Abe N; Takeuchi K
    Dig Dis Sci; 2010 Jun; 55(6):1570-80. PubMed ID: 19707872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peripheral urocortin inhibits gastric emptying and food intake in mice: differential role of CRF receptor 2.
    Wang L; Martínez V; Rivier JE; Taché Y
    Am J Physiol Regul Integr Comp Physiol; 2001 Nov; 281(5):R1401-10. PubMed ID: 11641109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential monoaminergic, neuroendocrine and behavioural responses after central administration of corticotropin-releasing factor receptor type 1 and type 2 agonists.
    de Groote L; Peñalva RG; Flachskamm C; Reul JM; Linthorst AC
    J Neurochem; 2005 Jul; 94(1):45-56. PubMed ID: 15953348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of Multisubstituted Corticotropin Releasing Factor (CRF) Peptide Antagonists (Astressins).
    Erchegyi J; Wang L; Gulyas J; Samant M; Perrin MH; Lewis K; Miller C; Vaughan J; Donaldson C; Fischer W; Low W; Yakabi S; Karasawa H; Taché Y; Rivier C; Rivier J
    J Med Chem; 2016 Feb; 59(3):854-66. PubMed ID: 26789203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Participation of corticotropin-releasing factor type 2 receptors in the acute, chronic and withdrawal actions of nicotine associated with feeding behavior in rats.
    Kamdi SP; Nakhate KT; Dandekar MP; Kokare DM; Subhedar NK
    Appetite; 2009 Dec; 53(3):354-62. PubMed ID: 19635511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice.
    Risbrough VB; Hauger RL; Pelleymounter MA; Geyer MA
    Psychopharmacology (Berl); 2003 Nov; 170(2):178-87. PubMed ID: 12845406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CRF receptor type 1 (but not type 2) located within the amygdala plays a role in the modulation of anxiety in mice exposed to the elevated plus maze.
    Cipriano AC; Gomes KS; Nunes-de-Souza RL
    Horm Behav; 2016 May; 81():59-67. PubMed ID: 27060334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential activation of CRF receptor subtypes removes stress-induced memory deficit and anxiety.
    Todorovic C; Radulovic J; Jahn O; Radulovic M; Sherrin T; Hippel C; Spiess J
    Eur J Neurosci; 2007 Jun; 25(11):3385-97. PubMed ID: 17553007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peripheral urocortin delays gastric emptying: role of CRF receptor 2.
    Nozu T; Martinez V; Rivier J; Taché Y
    Am J Physiol; 1999 Apr; 276(4):G867-74. PubMed ID: 10198329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential dose effects of central CRF and effects of CRF astressin on pig behavior.
    Salak-Johnson JL; Anderson DL; McGlone JJ
    Physiol Behav; 2004 Oct; 83(1):143-50. PubMed ID: 15501501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A balance theory of peripheral corticotropin-releasing factor receptor type 1 and type 2 signaling to induce colonic contractions and visceral hyperalgesia in rats.
    Nozu T; Takakusaki K; Okumura T
    Endocrinology; 2014 Dec; 155(12):4655-64. PubMed ID: 25279793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraperitoneal corticotropin-releasing factor and urocortin induce Fos expression in brain and spinal autonomic nuclei and long lasting stimulation of colonic motility in rats.
    Maillot C; Wang L; Million M; Taché Y
    Brain Res; 2003 Jun; 974(1-2):70-81. PubMed ID: 12742625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mouse strain differences in the behavioral effects of corticotropin-releasing factor (CRF) and the CRF antagonist alpha-helical CRF9-41.
    Conti LH; Costello DG; Martin LA; White MF; Abreu ME
    Pharmacol Biochem Behav; 1994 Jun; 48(2):497-503. PubMed ID: 8090821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Behavioral effects of central administration of the novel CRF antagonist astressin in rats.
    Spina MG; Basso AM; Zorrilla EP; Heyser CJ; Rivier J; Vale W; Merlo-Pich E; Koob GF
    Neuropsychopharmacology; 2000 Mar; 22(3):230-9. PubMed ID: 10693150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.